Streetbeat News

Products Services

F

Ford Motor Co reported an 86.1% increase in Q1 U.S. EV sales, totaling 20,223 units. Overall, Q1 U.S. vehicle sales rose by 6.8% to 508,083 units. The company anticipates continued growth in hybrid sales, particularly with more shipments of the new F-150 Hybrid to dealers.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 1:20 pm

SPOT

Spotify announced it will raise its subscription prices by $1-$2 per month in several markets. This move is part of a strategy to adjust its pricing plans and could impact the company's revenue and subscriber growth.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 1:20 pm

CART

PUBM

PubMatic (NASDAQ:PUBM) has announced a partnership with Instacart (NASDAQ:CART) to utilize Instacart's first-party retail media data for programmatic advertising on CTV and premium video campaigns. This collaboration aims to enhance advertising ROI by leveraging a privacy-compliant, scalable solution through PubMatic's Convert. Mars, a leading brand, will be among the first to activate this data for its campaigns. The partnership is part of PubMatic's broader strategy to expand its commerce media solutions, including the launch of Convert, a platform designed to streamline commerce media advertising.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 1:09 pm

EDBL

EDBLW

Edible Garden AG Incorporated (NASDAQ:EDBL, EDBLW) announced the transition of its business to Edible Garden Heartland in Grand Rapids, Michigan, focusing on vertical integration. This move allows the company to shift potted herb production in-house, enhancing margins by reducing production costs. The integration includes advanced technologies and high-speed packing lines, aiming for increased efficiency and profitability.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 1:06 pm

LGND

Ligand Pharmaceuticals (NASDAQ:LGND) has launched Pelthos Therapeutics to commercialize ZELSUVMI, a novel drug for treating molluscum contagiosum. Scott Plesha is appointed CEO of Pelthos. ZELSUVMI, developed with NITRICIL technology, is expected to be available in the US by late 2024. Ligand acquired ZELSUVMI's rights from Novan, Inc. in September 2023. Ligand aims to commercialize ZELSUVMI with partners, continuing its strategy of maximizing value through equity and royalty rights in new entities.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 1:05 pm

LBPH

Longboard Pharmaceuticals is set to present Phase 1b/2a clinical data from its PACIFIC Study at the AAN Annual Meeting on April 15. The data will also be featured in an encore presentation at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 1:05 pm

SPRY

ARS Pharmaceuticals has submitted a response to the FDA's Complete Response Letter (CRL) for neffy, addressing all additional requests including positive data from a repeat dose PK/PD study and updated testing showing no measurable nitrosamine levels. The submission triggers a review period of up to six months by the FDA.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 1:04 pm

ALLE

GOOG

GOOGL

Allegion has expanded its mobile credential offerings by integrating Schlage employee badges with Google Wallet, aiming to enhance security and convenience for staff. This collaboration between Allegion and Google signifies a step forward in leveraging technology for secure and efficient workplace access solutions.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 1:01 pm

HSDT

Helius Medical Technologies Inc (NASDAQ:HSDT) announced a partnership with Lovell Government Services to make its PoNS device available to federal healthcare systems, leading to a significant stock price increase. The device, indicated for gait deficit treatment in mild-to-moderate multiple sclerosis, has shown promising real-world results. Additionally, the company received HCPCS codes for the PoNS controller and is seeking marketing authorization for stroke treatment in the U.S.

Portfolio Pulse from Vandana Singh

April 03, 2024 | 12:55 pm

PINC

Beebe Healthcare has chosen Premier Inc. (PINC) as its strategic partner for supply chain operations. This partnership aims to enhance Beebe Healthcare's supply chain efficiency and reduce operational costs.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 12:54 pm